https://www.clinicaltrials.gov/ct2/show/NCT03926286?type=Intr&cond=Sjogren%27s+Syndrome&sort=nwst&draw=2&rank=9
Fecal Microbial Transplant (FMT) for Sjogrens Syndrome
Study Description
Go to sections
Brief Summary:
This is an open label study to evaluate the effect of Fecal Microbiota Transplantation (FMT) on the gut microbiome and Systemic parameters.
Condition or disease Intervention/treatment Phase
Sjogren’s Syndrome
Drug: FMP-30
Phase 1
Study Design
Go to sections
Study Type : Interventional
Estimated Enrollment : 10 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Fecal Microbial Transplant for Sjogrens Syndrome
Actual Study Start Date : April 15, 2019
Estimated Primary Completion Date : June 1, 2020
Estimated Study Completion Date : December 1, 2021
